文献速递类风湿关节炎

从关节痛发展为类风湿关节炎过程中的患者负担与关节炎症:ACPA阳性与ACPA阴性疾病是否相似?

Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

研究纳入845例临床疑似关节痛(CSA)患者,中位随访24个月,其中136例发展为炎症性关节炎(IA),355/505例CSA缓解。结果显示ACPA阳性与ACPA阴性患者中,患者负担均随IA发展而增加、随CSA缓解而降低;但ACPA阳性者各时间点患者负担更低,而亚临床关节炎症在ACPA阳性者中进展更快且持续更高。

要点

  • ACPA阳性与阴性CSA患者中,患者负担均随IA发展而增加、随CSA缓解而降低。
  • ACPA阳性患者各时间点患者负担均低于ACPA阴性患者。
  • ACPA阳性者亚临床关节炎症进展更快且缓解后仍持续更高。

核心结论

  • 在RA发展和CSA缓解过程中,ACPA阳性CSA患者较ACPA阴性患者患者负担更低但亚临床关节炎症更多。
  • 这些数据强化了ACPA阳性与ACPA阴性RA发病机制不同的观点,并鼓励进一步研究这些差异。

研究设计与样本

  • 研究纳入845例临床疑似关节痛(CSA)患者,中位随访24个月。
  • 136例患者发展为炎症性关节炎(IA),另有355/505例患者根据风湿科医生判断达到CSA缓解。
  • 患者负担(疼痛、晨僵、疲劳、功能障碍、出勤主义)在基线及4、12、24个月和IA发展时评估。
  • 手和足的亚临床关节炎症随时间采用1.5T MRI评估,使用线性混合模型和泊松混合模型分析。

主要发现

  • ACPA阳性和ACPA阴性患者中,患者负担均随IA发展而增加、随CSA缓解而降低。
  • ACPA阳性患者各时间点患者负担均低于ACPA阴性患者。
  • ACPA阳性IA发展过程中亚临床关节炎症 tended to increase more rapidly,发生率比(IRR)1.52(95% CI 0.94, 2.47),P = 0.089。
  • 达到CSA缓解的ACPA阳性患者较ACPA阴性患者亚临床关节炎症随时间持续更高,IRR 1.52(95% CI 1.07, 2.15),P = 0.018。
  • 进展至IA过程中患者负担变化与亚临床关节炎症变化的相关系数较弱,但在ACPA阳性者中 consistently 更高,例如功能障碍ρ = 0.29 vs 0.12。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ACPA-positive and ACPA-negative RA differ in underlying risk factors but have a similar clinical presentation at RA diagnosis. It is unknown what the ACPA-associated differences or similarities are during the symptomatic at-risk stage of RA, i.e. clinically suspect arthralgia (CSA). To deepen insights into these differences/similarities, we compared the course of symptoms/impairments and subclinical joint inflammation in the CSA phase during progression to inflammatory arthritis (IA) or to CSA resolution. METHODS: A total of 845 CSA patients were followed for a median of 24 months; 136 patients developed IA and an additional 355/505 patients had resolution of CSA according to rheumatologists. Patient burden (pain, morning stiffness, fatigue, functional disabilities, presenteeism) was assessed at baseline and 4, 12 and 24 months and at IA development. Subclinical joint inflammation in the hands and feet was assessed over time with 1.5T MRI. Linear and Poisson mixed models were used. RESULTS: In both ACPA-positive and ACPA-negative patients, patient burden increased towards IA development and decreased towards CSA resolution. However, patient burden was lower in ACPA-positive vs ACPA-negative disease at all timepoints. Conversely, subclinical joint inflammation tended to increase more rapidly during development of ACPA-positive IA [incidence rate ratio (IRR) 1.52 (95% CI 0.94, 2.47), P = 0.089] and remained higher over time in ACPA-positive CSA patients achieving resolution compared with ACPA-negative patients [IRR 1.52 (95% CI 1.07, 2.15), P = 0.018]. Although correlation coefficients between changes in patient burden and subclinical joint inflammation during progression to IA were weak, they were consistently higher in ACPA-positive than ACPA-negative disease, e.g. ρ = 0.29 vs 0.12 for functional disabilities. CONCLUSION: During RA development and CSA resolution, ACPA-positive CSA patients have lower patient burden but more subclinical joint inflammation than ACPA-negative CSA patients. These data strengthen the notion that the development of ACPA-positive and ACPA-negative RA is pathophysiologically different and encourage further research on these differences.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Khidir SJH, Krijbolder DI, Glas HK, et al. Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease? Rheumatology (Oxford). 2024. PMID: 38261628. doi:10.1093/rheumatology/keae044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。